# Peru Vanderbilt – PREvention through VacciNation Training (PREVENT) program

> **NIH NIH D43** · VANDERBILT UNIVERSITY MEDICAL CENTER · 2024 · $246,719

## Abstract

SUMMARY
While vaccination is the most efficient tool for the prevention of infectious diseases both in developed and
developing countries, the implementation of effective vaccination programs is challenging. The development,
introduction and implementation of effective vaccination depends on availability of locally generated evidence,
especially data required by local regulatory authorities. An essential requirement to make this happen is to
have well-trained local researchers who have a clear understanding of the process behind vaccine
development, vaccine introduction and program implementation. Training of researchers on the achieved
impact of vaccination on antimicrobial resistant infections, the relevance of indirect protection and the biological
pressure induced by vaccination programs are examples of well-established vaccination topics that are
commonly overlooked. A proper understanding of the effects of vaccination on unvaccinated groups through
indirect or herd immunity is crucial, but this is frequently misinterpreted. Moreover, there is a growing distrust in
vaccines and vaccination programs that needs to be addressed by researchers with appropriate technical
skills. Thus, there is a growing global need for training in vaccinology and the study of vaccine-preventable
diseases encompassing the entire process from vaccine development to field implementation and program
evaluation. To address these needs, Vanderbilt University Medical Center (VUMC), the Instituto de
Investigacion Nutricional (IIN) and the Universidad Peruana Cayetano Heredia (UPCH) are joining forces to
build the Peru-Vanderbilt Prevention through Vaccination Training Program (PREVENT). The overall goal of
PREVENT is to develop a cadre of researchers and educators equipped with modern knowledge and expertise
to lead vaccine preventable diseases research and training in Peru and to encourage US-based researchers to
engage in vaccination research in low- and middle-income country (LMICs). PREVENT builds on the very
successful 14-year Research Partnership with the IIN and UPCH and on the Vanderbilt Vaccine Training and
Evaluation Unit and the Division of Pharmacoepidemiology's expertise in the study of vaccine preventable
diseases, training and mentoring. PREVENT will support 10 medium-long term trainees (Master's, PhD and
faculty fellowships). Specifically, PREVENT aims to 1) Train a cadre of researchers and educators (trainers) to
conduct multidisciplinary vaccine preventable diseases research and build training capacity in Peru; 2) Train
scientists and future leaders in vaccine-preventable diseases research in Peru; and, 3) Ensure and document
PREVENT's long-term impact. The ongoing IIN/UPCH-Vanderbilt Research Partnership has proven highly
productive and successful. A new training program focusing on Vaccinology and the study of vaccine
preventable diseases and the growth of structures and efforts to increase grant success will move IIN and
UPCH toward a new horizon in ...

## Key facts

- **NIH application ID:** 10839939
- **Project number:** 5D43TW012468-02
- **Recipient organization:** VANDERBILT UNIVERSITY MEDICAL CENTER
- **Principal Investigator:** CARLOS G GRIJALVA
- **Activity code:** D43 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $246,719
- **Award type:** 5
- **Project period:** 2023-05-01 → 2027-12-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10839939

## Citation

> US National Institutes of Health, RePORTER application 10839939, Peru Vanderbilt – PREvention through VacciNation Training (PREVENT) program (5D43TW012468-02). Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/grant/nih/10839939. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*